Benign Paroxysmal Positional Vertigo

Back

Practice Essentials

Benign paroxysmal positional vertigo (BPPV) is probably the most common cause of vertigo in the United States. It has been estimated that at least 20% of patients who present to the physician with vertigo have BPPV. However, because BPPV is frequently misdiagnosed, this figure may not be completely accurate and is probably an underestimation. Since BPPV can occur concomitantly with other inner ear diseases (for example, one patient may have both Ménière disease and BPPV at once), statistical analysis may be skewed toward lower numbers.[1]

BPPV was first described by Barany in 1921. The characteristic nystagmus and vertigo associated with positioning changes were attributed at that time to the otolithic organs. In 1952, Dix and Hallpike performed the provocative positional testing named in their honor, shown below. They further defined classic nystagmus and went on to localize the pathology to the proper ear during provocation.



View Image

The patient is placed in a sitting position with the head turned 45° towards the affected side and then reclined past the supine position.

BPPV is a complex disorder to define; because an evolution has occurred in the understanding of its pathophysiology, an evolution has also occurred in its definition. As more interest is focused on BPPV, new variations of positional vertigo have been discovered. What was previously grouped as BPPV is now subclassified by the offending semicircular canal (SCC; ie, posterior superior SCC vs lateral SCC) and, although controversial, further divided into canalithiasis and cupulolithiasis (depending on its pathophysiology). (A literature review by Anagnostou et al indicated that approximately 3% of all BPPV cases consist of the anterior canal variant of the condition.[2] )

BPPV is defined as an abnormal sensation of motion that is elicited by certain critical provocative positions. The provocative positions usually trigger specific eye movements (ie, nystagmus). The character and direction of the nystagmus are specific to the part of the inner ear affected and the pathophysiology.

Although some controversy exists regarding the 2 pathophysiologic mechanisms, canalithiasis and cupulolithiasis, agreement is growing that the entities actually coexist and account for different subspecies of BPPV. Canalithiasis (literally, "canal rocks") is defined as the condition of particles residing in the canal portion of the SCCs (in contradistinction to the ampullary portion). These densities are considered to be free floating and mobile, causing vertigo by exerting a force. Conversely, cupulolithiasis (literally, "cupula rocks") refers to densities adhered to the cupula of the crista ampullaris. Cupulolith particles reside in the ampulla of the SCCs and are not free floating.

Classic BPPV is the most common variety of BPPV. It involves the posterior SCC and is characterized by the following:

Because the type of BPPV is defined by the distinguishing type of nystagmus, defining and explaining the characterizing nystagmus are also important.

Nystagmus is defined as involuntary eye movements usually triggered by inner ear stimulation. It usually begins as a slow pursuit movement followed by a fast, rapid resetting phase. Nystagmus is named by the direction of the fast phase. Thus, nystagmus may be termed right beating, left beating, up-beating (collectively horizontal), down-beating (vertical), or direction changing.

If the movements are not purely horizontal or vertical, the nystagmus may be deemed rotational. In rotational nystagmus, the terminology becomes a bit more loose or unconventional. Terms such as clockwise and counterclockwise seem useful until discrepancies regarding point of view arise: clockwise to the patient is counterclockwise to the observer. Right versus left terminology is poorly descriptive because as the top half of the eye rotates right, the bottom half moves left.

Rotational nystagmus also can be described as geotropic and ageotropic. Geotropic means "toward earth" and refers to the upper half of the eye. Ageotropic refers to the opposite movement. If the head is turned to the right, and the eye rotation is clockwise from the patient's point of view (top half turns to the right and toward the ground), then the nystagmus is geotropic. If the head is turned toward the left, then geotropic nystagmus is a counterclockwise rotation. This term is particularly useful in describing BPPV nystagmus because the word geotropic remains appropriate whether the right or the left side is involved.

These 2 terms are useful only when the head is turned. If the patient is supine and looking straight up, these terms cannot be used. Fortunately, the nystagmus associated with BPPV usually is provoked with the head turned to one side. The most accurate way to define nystagmus is by terming it clockwise or counterclockwise from the patient's point of view.

Symptoms of benign paroxysmal positional vertigo

The onset of BPPV is typically sudden. Many patients wake up with the condition, noticing the vertigo while trying to sit up suddenly. Thereafter, propensity for positional vertigo may extend for days to weeks, occasionally for months or years. In many, the symptoms periodically resolve and then recur.

The severity covers a wide spectrum. In patients with extreme cases, the slightest head movement may be associated with nausea and vomiting. Despite strong nystagmus, other patients seem relatively unfazed.

People who have BPPV do not usually feel dizzy all the time. Severe dizziness occurs as attacks triggered by head movements. At rest between episodes, patients usually have few or no symptoms. However, some patients complain of a continual sensation of a "foggy or cloudy" sensorium.

Diagnosis and management of benign paroxysmal positional vertigo

The Dix-Hallpike maneuver is the standard clinical test for BPPV. The finding of classic rotatory nystagmus with latency and limited duration is considered pathognomonic. A negative test result is meaningless except to indicate that active canalithiasis is not present at that moment.

The Dix-Hallpike maneuver is performed by rapidly moving the patient from a sitting position to the supine position with the head turned 45° to the right. After waiting approximately 20-30 seconds, the patient is returned to the sitting position. If no nystagmus is observed, the procedure is then repeated on the left side.

Treatment options for BPPV include watchful waiting, vestibulosuppressant medication, vestibular rehabilitation, canalith repositioning, and surgery. Since the benefit-to-risk ratio is so high with canalith repositioning, it appears to be the obvious first choice among treatment modalities.

Surgery is usually reserved for those in whom the canalith repositioning procedure (CRP) fails. Options include labyrinthectomy, posterior canal occlusion, singular neurectomy, vestibular nerve section, and transtympanic aminoglycoside application.

Pathophysiology

To understand pathophysiology, an understanding of normal SCC anatomy and physiology is necessary. Each inner ear contains 3 SCCs oriented in 3 perpendicular planes; the SCCs mediate spatial orientation. Each canal consists of a tubular arm (crura) that sprouts from a large barrellike compartment, much like the handle of a coffee mug sprouts from the mug. Each of these arms has a dilated (ampullary) end located near the top or front portion that houses the crista ampullaris (nerve receptors).

The crista ampullaris has a sail-like tower, the cupula, that detects the flow of fluid within the SCC. If a person turns suddenly to the right, the fluid within the right horizontal canal lags behind, causing the cupula to be deflected left (toward the ampulla, or ampullopetally). This deflection is translated into a nerve signal that confirms the head is rotating to the right.

In simple terms, the cupula acts as a 3-way switch that, when pressed one way, appropriately gives the body a sensation of motion. The middle or neutral position reflects no motion. When the switch is moved the opposite way, the sensation of motion is in the opposite direction.

Particles in the canal slow and even reverse the movement of the cupula switch and create signals that are incongruous with the actual head movements. This mismatch of sensory information results in the sensation of vertigo.

Cupulolithiasis theory

In 1962, Harold Schuknecht, MD, proposed the cupulolithiasis (heavy cupula) theory as an explanation for BPPV. Via photomicrographs, he discovered basophilic particles or densities that were adherent to the cupula. He postulated that the posterior semicircular canal (PSC) was rendered sensitive to gravity by these abnormal dense particles attached to or impinging upon the cupula.

This theory is analogous to the situation of a heavy object attached to the top of a pole. The extra weight makes the pole unstable and thus harder to keep in the neutral position. In fact, the pole is easily prone to "clunk" from one side to the other depending on the direction it is tilted. Once the position is reached, the weight of the particles keeps the cupula from springing back to neutral. This is reflected by the persistent nystagmus and explains the dizziness when a patient is tilted backward.

Canalithiasis theory

In 1980, Epley published his theories regarding canalithiasis.[3] He thought that the symptoms of BPPV were much more consistent with free-moving densities (canaliths) in the posterior SCC rather than fixed densities attached to the cupula. While the head is upright, the particles sit in the PSC at the most gravity-dependent position. When the head is tilted back supine, the particles are rotated up approximately 90° along the arc of the PSC. After a momentary (inertial) lag, gravity pulls the particles down the arc. This causes the endolymph to flow away from the ampulla and causes the cupula to be deflected. The cupular deflection produces nystagmus. Reversal of the rotation (sitting back up) causes reversal of the cupular deflection and thus dizziness with nystagmus beating in the opposite direction.

This model can be compared with pebbles inside a tire. As the tire is rolled, the pebbles are picked up momentarily and then tumble down with gravity. This tumbling triggers the nerve inappropriately and causes dizziness. Reversal of the rotation obviously causes reversal of the flow and reversal of the dizziness direction.

Canal densities would better explain the delay (latency), transient nystagmus, and reversal on return to upright than would cupular densities. This supports canalithiasis rather than cupulolithiasis as the mechanism for classic BPPV.

The canalithiasis theory received further corroboration by Parnes and McClure in 1991 with the discovery of free densities in PSC at surgery.

Epidemiology

Frequency

United States

In one study, the age- and sex-adjusted prevalence of BPPV was 64 per 100,000. Other studies corroborate this finding.

Race

Little published information is available on racial predilection.

Sex

The sex distribution seems to indicate a predilection for women (64%).

Age

BPPV seems to have a predilection for the older population (average age, 51-57.2 y). It is rarely observed in individuals younger than 35 years without a history of antecedent head trauma.

History

The onset of benign paroxysmal positional vertigo (BPPV) is typically sudden. Many patients wake up with the condition, noticing the vertigo while trying to sit up suddenly. Thereafter, propensity for positional vertigo may extend for days to weeks, occasionally for months or years. In many, the symptoms periodically resolve and then recur.

The severity covers a wide spectrum. In patients with extreme cases, the slightest head movement may be associated with nausea and vomiting. Despite strong nystagmus, other patients seem relatively unfazed.

People who have BPPV do not usually feel dizzy all the time. Severe dizziness occurs as attacks triggered by head movements. At rest between episodes, patients usually have few or no symptoms. However, some patients complain of a continual sensation of a "foggy or cloudy" sensorium.

Classic BPPV is usually triggered by the sudden action of moving from the erect position to the supine position while angling the head 45° toward the side of the affected ear. Merely being in the provocative position is not enough. The head actually must move to the offending pose. After reaching the provocative position, a lag period of a few seconds occurs before the spell strikes. When BPPV is triggered, patients feel as though they are suddenly thrown into a rolling spin, toppling toward the side of the affected ear. Symptoms start very violently and usually dissipate within 20 or 30 seconds. This sensation is triggered again upon sitting erect; however, the direction of the nystagmus is reversed.

Physical

See the list below:

A study by Yetiser and Ince indicated that the head-roll maneuver is the most effective positioning test for diagnosing lateral canal BPPV, in a comparison with the head-bending and lying-down positioning tests. The study, which involved 78 patients with lateral canal BPPV, found that using the head-roll maneuver, the affected side was located in 75% of patients with apogeotropic nystagmus and in 95.6% of patients with geotropic nystagmus.[4]

Causes

A few factors predispose patients to BPPV. These include inactivity, acute alcoholism, major surgery, and central nervous system (CNS) disease. A complete neurotologic examination is important because many patients have concomitant ear pathology, as follows:

A study by Chang et al suggested that BPPV can be triggered by dental procedures. The study, which included 768 patients with BPPV and 1536 controls, found that within 1 month before they were diagnosed, 9.2% of the patients with BPPV had undergone dental treatment, compared with 5.5% of controls within a month before they were identified. Adjustments for demographic factors and comorbidities indicated that a positive relationship exists between recent dental procedures and BPPV.[5]

A retrospective study by Faralli et al indicated that in persons with migraine headache and BPPV, the onset of BPPV tends to occur earlier in life than it does in patients with this form of vertigo but no migraine. The investigators found that the mean age at BPPV onset for patients with migraine was 39 years, compared with 53 years for patients without migraine. In addition, highly recurrent BPPV was found in 19.4% of the migraine patients, compared with 7.3% of persons without migraine. Moreover, the frequency of atypical eye movements and Ménière-like vertigo was greater in patients with both migraine and highly recurrent BPPV. Faralli and colleagues stated, however, that it has not yet been determined whether a direct pathophysiologic association exists between migraine and BPPV.[6]

A study by Picciotti et al indicated that the recurrence of BPPV is significantly associated with the employment of antihypertensives in single use, central nervous system agents, proton-pump inhibitors, vitamin D, and thyroid hormones.[7]

A report by Messina et al indicated that hypertension, dyslipidemia, and preexisting cardiovascular comorbidities are risk factors for recurrent episodes of BPPV, with the odds ratios ranging from 1.84 to 2.31.[8]

Laboratory Studies

Because the Dix-Hallpike maneuver is pathognomonic, laboratory tests are not needed to make the diagnosis of benign paroxysmal positional vertigo (BPPV). However, since a high association with inner ear disease exists, laboratory workup may be needed to delineate these other pathologies.

Imaging Studies

Imaging studies are not needed in the workup of a patient in whom BPPV is suspected.

Other Tests

See the list below:

Medical Care

Treatment options include watchful waiting, vestibulosuppressant medication, vestibular rehabilitation, canalith repositioning, and surgery.

Watchful waiting

Since benign paroxysmal positional vertigo (BPPV) is benign and can resolve without treatment in weeks to months, some have argued that simple observation is all that is needed. Conversely, this involves weeks or months of discomfort and vertigo, with the danger of falls and other mishaps from the episodic vertigo spells (eg, patients who work on scaffolding may fall easily).

Vestibulosuppressant medication

This medication usually does not stop the vertigo. Although it may provide minimal relief for some patients, it does not solve the problem; it only masks the problem. Adverse effects of grogginess and sleepiness also complicate the issue of medication.

Vestibular rehabilitation

Vestibular rehabilitation is a noninvasive therapy that can have success after lengthy periods. Unfortunately, it causes repeated stimulation of vertigo while the patient is performing the therapeutic maneuvers. Patients can be instructed in Cawthorne exercises that seem to help by dispersing particles.

Canalith repositioning

Since the benefit-to-risk ratio is so high with canalith repositioning, it appears to be the obvious first choice among treatment modalities.

Particle repositioning is represented by two major maneuvers that developed simultaneously, yet independently, in the United States and France. These methods are the Epley maneuver and the Semont maneuver, and many minor variations of each of the methods exist. Both involve movements of the head to rearrange displaced particles. The Semont maneuver involves rapid and vigorous side-to-side head and body movements. The Epley maneuver is gentler and is described below. The canalith repositioning procedure (CRP) is a simple and noninvasive office treatment that is designed to cure BPPV in 1-2 sessions. See the image below. This therapy, in experienced hands, has a success rate of more than 95% for patients with BPPV.



View Image

The patient is placed in a sitting position with the head turned 45° towards the affected side and then reclined past the supine position.

A retrospective study by Tirelli et al indicated that patients with recurrent BPPV who undergo repeated CRP have a significantly increased dizziness recovery rate but do not have a significant difference in BPPV recurrence, compared with patients who have undergone an initial treatment with CRP but not repeated procedures.[9]

A retrospective study by Yoon et al of 1900 patients indicated that the following risk factors increase the chance that a patient with BPPV will need multiple CRPs: longer pretreatment duration of vertigo, involvement of bilateral or multiple canals, and age over 50 years.[10]

A study by Power et al found that 91% of cases of posterior canal BPPV were successfully managed with two canalith repositioning maneuvers or less, while 88% of cases of horizontal canal BPPV were effectively treated with two such maneuvers. A higher number of treatments were required for bilateral posterior canal and multiple canal BPPV, as well as for patients who experienced canal conversion.[11]

Multi-axial positioning devices

Research into multi-axial positioning devices that can perform canalith repositioning using 360º rotation in the proper plane of the semicircular canals has been conducted. The results are promising, but these devices need more study.

Epley procedure

The Epley procedure is as follows (patient with right-sided BPPV in this example):

A Dix-Hallpike test is performed immediately following the procedure. If nystagmus is observed, the procedure is repeated. After the procedure, the patient is instructed to avoid agitation of the head for approximately 48 hours while the particles settle and to return in 1 week for a follow-up examination.

The previously mentioned literature review by Anagnostou et al indicated that the anterior canal variant of BPPV can be successfully treated with the Epley and Yacovino maneuvers, as well as with various nonstandard maneuvers. The study, which included 31 citations, found a success rate of over 75% for each of these three types of maneuvers.[2]

Surgical Care

Surgery is usually reserved for those in whom CRP fails. It is not a first-line treatment because it is invasive and holds the possibility of complications such as hearing loss and facial nerve damage. Options include labyrinthectomy, posterior canal occlusion, singular neurectomy, vestibular nerve section, and transtympanic aminoglycoside application. All have a high chance of vertigo control.

Complete destruction of the affected inner ear is excessive, considering that only the posterior semicircular canal is involved. Therefore, the authors would not recommend labyrinthectomy or vestibular nerve section, except in the most extreme of cases.

Singular neurectomy, while theoretically a reasonable choice because it is directed at denervation of the offending posterior semicircular canal, is technically difficult and has only been mastered by a handful of surgeons. Furthermore, some of these patients have significant postoperative imbalance issues.

The most viable surgical option for patients who have failed CRP is posterior canal occlusion. The idea is to stop the benign positional vertigo by collapsing the posterior canal, immobilizing the movement of particles through the canal. This procedure is performed through a standard mastoidectomy approach. The offending posterior semicircular canal is isolated. The hard bone is drilled down with diamond burrs to expose the membranous labyrinth without spilling much perilymphatic fluid. The membranous labyrinth containing the endolymphatic fluid is compressed so that the flow of the length is disrupted. This keeps the particles from traveling through the endolymphatic space, thereby stopping the dizziness.

Success rates are in the 95th percentile range. Postoperative imbalance is not uncommon for a few weeks to months. This is typically treated with postoperative vestibular rehabilitation.

Activity

After CRP treatment, patients are instructed to avoid lying completely flat for 24-48 hours. Sleeping with the head elevated on a few pillows is recommended. Avoidance of jarring activities or gymnastic flips is recommended.

A correlation has been demonstrated between the head-lying side during sleep and the side affected by benign paroxysmal positional vertigo. Patients may want to adjust their sleeping positions accordingly to prevent recurrence.[12]

Guidelines Summary

In 2017, the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF)released an update to a 2008 guideline regarding benign paroxysmal positional vertigo (BPPV). The update included recommendations that clinicians do as follows[13, 14, 15] :

Medication Summary

Vestibulosuppressant medication can be used to mitigate the severity of vertigo. Unfortunately, many times it is not effective and only masks the problem. Adverse effects of grogginess and sleepiness are also possible.

Although steroids have some beneficial effects in acute vertigo syndromes such as Ménière disease, they seem to have no value in the treatment of benign paroxysmal positional vertigo (BPPV).

Complications

Serious complications of canalith repositioning procedure (CRP) are rare.

Prognosis

Prognosis following CRP is usually good. Spontaneous remission can occur within 6 weeks, although some cases never remit. Once treated, the recurrence rate is 10-25%.

A retrospective study by Picciotti et al indicated that in individuals who have experienced BPPV, the risk of recurrence is higher in female patients, older patients, and patients with comorbidities (particularly psychiatric disorders). The persistence rate was significantly higher in persons with posttraumatic BPPV (45.2%) than in those with nontraumatic BPPV (20.5%). The study included 475 patients, including 139 (29.3%) with recurrence of BPPV.[16]

A retrospective study by Tan et al indicated that patients with hypertension comorbid with BPPV have a greater BPPV recurrence rate than do those with idiopathic BPPV.[17]

Patient Education

For patient education resources, see the Brain and Nervous System Center, as well as Benign Positional Vertigo, Vertigo, and Dizziness.

What is the prevalence of benign paroxysmal positional vertigo (BPPV)?What is the historical history of benign paroxysmal positional vertigo (BPPV)?What is benign paroxysmal positional vertigo (BPPV)?How are the canalithiasis and cupulolithiasis forms of benign paroxysmal positional vertigo (BPPV) defined?How is classic benign paroxysmal positional vertigo (BPPV) characterized?How is nystagmus characterized in benign paroxysmal positional vertigo (BPPV)?What is the standard clinical test for benign paroxysmal positional vertigo (BPPV)?How is the Dix-Hallpike maneuver performed in the evaluation of benign paroxysmal positional vertigo (BPPV)?What are the treatment options for benign paroxysmal positional vertigo (BPPV)?What is the role of surgery in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the pathophysiology of vertigo?What is the cupulolithiasis theory of the pathogenesis of benign paroxysmal positional vertigo (BPPV)?What is the canalithiasis theory of the pathogenesis of benign paroxysmal positional vertigo (BPPV)?What is the prevalence of benign paroxysmal positional vertigo (BPPV) in the US?What are the racial predilections o benign paroxysmal positional vertigo (BPPV)?How does the prevalence of benign paroxysmal positional vertigo (BPPV) vary by sex?What are the age predilections of benign paroxysmal positional vertigo (BPPV)?What are the signs and symptoms of benign paroxysmal positional vertigo (BPPV)?Which physical findings are characteristic of benign paroxysmal positional vertigo (BPPV)?How is the Dix-Hallpike maneuver performed, and which findings indicate benign paroxysmal positional vertigo (BPPV)?What do nystagmus findings indicate in the evaluation of benign paroxysmal positional vertigo (BPPV)?What is the most effective positioning test for diagnosing lateral canal benign paroxysmal positional vertigo (BPPV)?What are the risk factors for benign paroxysmal positional vertigo (BPPV)?What is the role of dental procedures in the etiology of benign paroxysmal positional vertigo (BPPV)?What is the role of migraine headache in the etiology of benign paroxysmal positional vertigo (BPPV)?What are the risk factors for recurrent benign paroxysmal positional vertigo (BPPV)?Which conditions should be included in the differential diagnoses for benign paroxysmal positional vertigo (BPPV)?What are the differential diagnoses for Benign Paroxysmal Positional Vertigo?What is the role of lab studies in the workup of benign paroxysmal positional vertigo (BPPV)?What is the role of imaging studies in the workup of benign paroxysmal positional vertigo (BPPV)?Which tests are performed in the workup of benign paroxysmal positional vertigo (BPPV)?What are the treatment options for benign paroxysmal positional vertigo (BPPV)?What are the limitations of watchful waiting in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the role of vestibulosuppressant medication in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the role of vestibular rehabilitation in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the role of canalith repositioning (CRP) in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the efficacy of canalith repositioning (CRP) for the treatment of benign paroxysmal positional vertigo (BPPV)?Which factors may indicate repeated need for canalith repositioning (CRP) during treatment of benign paroxysmal positional vertigo (BPPV)?What is the efficacy of multi-axial positioning devices in the treatment of benign paroxysmal positional vertigo (BPPV)?How is the Epley procedure performed in the treatment of benign paroxysmal positional vertigo (BPPV)?Which CRP maneuvers are effective in the treatment of benign paroxysmal positional vertigo (BPPV)?When is surgery indicated in the treatment of benign paroxysmal positional vertigo (BPPV)?Which surgical procedures are contraindicated for the treatment of benign paroxysmal positional vertigo (BPPV)?Which is the role of singular neurectomy in the treatment of benign paroxysmal positional vertigo (BPPV)?What is the role of posterior canal occlusion in the treatment of benign paroxysmal positional vertigo (BPPV)?What activity modifications are needed following treatment of benign paroxysmal positional vertigo (BPPV)?What are the AAO-HNSF recommendations for the treatment of benign paroxysmal positional vertigo (BPPV)?What are the limitations of medications for the treatment of benign paroxysmal positional vertigo (BPPV)?What is the role of steroids in the treatment of benign paroxysmal positional vertigo (BPPV)?What are possible complications of canalith repositioning procedure (CRP) for the treatment of benign paroxysmal positional vertigo (BPPV)?What is the prognosis of benign paroxysmal positional vertigo (BPPV) following canalith repositioning procedure (CRP)?What is the risk of recurrence of benign paroxysmal positional vertigo (BPPV)?What are some patient education resources for benign paroxysmal positional vertigo (BPPV)?

Author

John C Li, MD, Private Practice in Otology and Neurotology; Medical Director, Balance Center

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director, Clinical Center for Auditory, Vestibular, and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Chief of Pediatric Otology, Children’s Medical Center of Dallas; President of Medical Staff, Parkland Memorial Hospital; Adjunct Professor of Communicative Disorders, School of Behavioral and Brain Sciences, Chief of Medical Service, Callier Center for Communicative Disorders, University of Texas School of Human Development

Disclosure: Received honoraria from Alcon Labs for consulting; Received honoraria from Advanced Bionics for board membership; Received honoraria from Cochlear Corp for board membership; Received travel grants from Med El Corp for consulting.

Chief Editor

Arlen D Meyers, MD, MBA, Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;The Physicians Edge;Sync-n-Scale;mCharts<br/>Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa;Proforma;Neosoma<br/> Received stock from RxRevu; Received ownership interest from Cerescan for consulting; .

Additional Contributors

Michael E Hoffer, MD, Director, Spatial Orientation Center, Department of Otolaryngology, Naval Medical Center of San Diego

Disclosure: Received royalty from American biloogical group for other.

Acknowledgements

John Epley, MD Director, Portland Otologic Clinic

John Epley, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, and Oregon Medical Association

Disclosure: Nothing to disclose.

References

  1. Palmeri R, Dulebohn SC. Vertigo, Benign Paroxysmal Position (BPPV). 2017 Jun. [View Abstract]
  2. Anagnostou E, Kouzi I, Spengos K. Diagnosis and Treatment of Anterior-Canal Benign Paroxysmal Positional Vertigo: A Systematic Review. J Clin Neurol. 2015 May 28. [View Abstract]
  3. Epley JM. New dimensions of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 1980 Sep-Oct. 88(5):599-605. [View Abstract]
  4. Yetiser S, Ince D. Diagnostic Role of Head-Bending and Lying-Down Tests in Lateral Canal Benign Paroxysmal Positional Vertigo. Otol Neurotol. 2015 May 1. [View Abstract]
  5. Chang TP, Lin YW, Sung PY, Chuang HY, Chung HY, Liao WL. Benign Paroxysmal Positional Vertigo after Dental Procedures: A Population-Based Case-Control Study. PLoS One. 2016. 11 (4):e0153092. [View Abstract]
  6. Faralli M, Cipriani L, Del Zompo MR, et al. Benign paroxysmal positional vertigo and migraine: analysis of 186 cases. B-ENT. 2014. 10(2):133-9. [View Abstract]
  7. Picciotti PM, Di Cesare T, Tricarico L, De Corso E, Galli J, Paludetti G. Is drug consumption correlated with benign paroxysmal positional vertigo (BPPV) recurrence?. Eur Arch Otorhinolaryngol. 2020 Feb 20. [View Abstract]
  8. Messina A, Casani AP, Manfrin M, Guidetti G. Italian survey on benign paroxysmal positional vertigo. Acta Otorhinolaryngol Ital. 2017 Aug. 37 (4):328-35. [View Abstract]
  9. Tirelli G, Nicastro L, Gatto A, Tofanelli M. Repeated canalith repositioning procedure in BPPV: Effects on recurrence and dizziness prevention. Am J Otolaryngol. 2017 Jan - Feb. 38 (1):38-43. [View Abstract]
  10. Yoon J, Lee JB, Lee HY, Lee BD, Lee CK, Choi SJ. Potential Risk Factors Affecting Repeated Canalith Repositioning Procedures in Benign Paroxysmal Positional Vertigo. Otol Neurotol. 2018 Feb. 39 (2):206-11. [View Abstract]
  11. Power L, Murray K, Szmulewicz DJ. Characteristics of assessment and treatment in Benign Paroxysmal Positional Vertigo (BPPV). J Vestib Res. 2019 Dec 13. [View Abstract]
  12. Shim DB, Kim JH, Park KC, Song MH, Park HJ. Correlation between the head-lying side during sleep and the affected side by benign paroxysmal positional vertigo involving the posterior or horizontal semicircular canal. Laryngoscope. 2012 Feb 16. [View Abstract]
  13. [Guideline] Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017 Mar. 156 (3_suppl):S1-S47. [View Abstract]
  14. [Guideline] Garcia J. New guidelines for benign paroxysmal positional vertigo. Medscape Medical News. 2017 Mar 1.
  15. [Guideline] Bhattacharyya N, Baugh RF, Orvidas L, et al. Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2008 Nov. 139(5 Suppl 4):S47-81. [View Abstract]
  16. Picciotti PM, Lucidi D, De Corso E, Meucci D, Sergi B, Paludetti G. Comorbidities and recurrence of benign paroxysmal positional vertigo: personal experience. Int J Audiol. 2016 May. 55 (5):279-84. [View Abstract]
  17. Tan J, Deng Y, Zhang T, Wang M. Clinical characteristics and treatment outcomes for benign paroxysmal positional vertigo comorbid with hypertension. Acta Otolaryngol. 2016 Nov 14. 1-3. [View Abstract]
  18. [Guideline] Fife TD, Iverson DJ, Lempert T, et al. Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2008 May 27. 70(22):2067-74. [View Abstract]
  19. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 1992 Sep. 107(3):399-404. [View Abstract]
  20. Fung K, Hall SF. Particle repositioning maneuver: effective treatment for benign paroxysmal positional vertigo. J Otolaryngol. 1996 Aug. 25(4):243-8. [View Abstract]
  21. Herdman SJ, Tusa RJ, Zee DS, et al. Single treatment approaches to benign paroxysmal positional vertigo. Arch Otolaryngol Head Neck Surg. 1993 Apr. 119(4):450-4. [View Abstract]
  22. Li JC. Mastoid oscillation: a critical factor for success in canalith repositioning procedure. Otolaryngol Head Neck Surg. 1995 Jun. 112(6):670-5. [View Abstract]
  23. Li JC, Epley J. The 360-degree maneuver for treatment of benign positional vertigo. Otol Neurotol. 2006 Jan. 27(1):71-7. [View Abstract]
  24. Massoud EA, Ireland DJ. Post-treatment instructions in the nonsurgical management of benign paroxysmal positional vertigo. J Otolaryngol. 1996 Apr. 25(2):121-5. [View Abstract]
  25. Roberts RA, Gans RE, Montaudo RL. Efficacy of a new treatment maneuver for posterior canal benign paroxysmal positional vertigo. J Am Acad Audiol. 2006 Sep. 17 (8):598-604. [View Abstract]
  26. Smouha EE, Roussos C. Atypical forms of paroxysmal positional nystagmus. Ear Nose Throat J. 1995 Sep. 74(9):649-56. [View Abstract]
  27. Weider DJ, Ryder CJ, Stram JR. Benign paroxysmal positional vertigo: analysis of 44 cases treated by the canalith repositioning procedure of Epley. Am J Otol. 1994 May. 15(3):321-6. [View Abstract]

The patient is placed in a sitting position with the head turned 45° towards the affected side and then reclined past the supine position.

The patient is placed in a sitting position with the head turned 45° towards the affected side and then reclined past the supine position.

The patient is placed in a sitting position with the head turned 45° towards the affected side and then reclined past the supine position.

The patient is then brought back up to the sitting position.

Next, the patient is rolled 180° from the affected side to the opposite side. Note that the position of the head is 45° toward the affected side before the roll. The head winds up facing down, 180° away from the starting position.